Home › Essential Thrombocythemia › Missouri › St. Louis
Essential Thrombocythemia clinical trials in St. Louis, MO
4 studies for Essential Thrombocythemia are looking for participants at sites in and around St. Louis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
RecruitingPhase 1
- Washington University School of Medicine, St Louis
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
RecruitingPhase 3
- Washington University School of Medicine, St Louis
A Study to Evaluate DMR-001 in Participants With CALR-mutant Myeloproliferative Neoplasms
RecruitingPhase 1
- Site US08, St Louis
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
RecruitingPhase 1
- Washington University School of Medicine, St Louis
Essential Thrombocythemia trials in other cities
- New York City, NY8 studies
- Durham, NC7 studies
- Nashville, TN5 studies
- Salt Lake City, UT5 studies
- Boston, MA5 studies
- Baltimore, MD5 studies
- Mountain View, CA4 studies
- Irvine, CA4 studies
- Columbus, OH4 studies
- Miami, FL4 studies
- Chicago, IL4 studies
- Houston, TX4 studies
Other studies in St. Louis
- Non-Small Cell Lung Cancer68 studies
- Breast Cancer63 studies
- Metastatic Cancer52 studies
- Cancer (all types)51 studies
- Colorectal Cancer51 studies
- Prostate Cancer45 studies
- Ovarian Cancer37 studies
- Lung Cancer37 studies
- Pancreatic Cancer33 studies
- Head and Neck Squamous Cell Carcinoma32 studies
- Endometrial Cancer29 studies
- Multiple Myeloma26 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.